Literature DB >> 7484080

Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders.

K J Lamers1, B G van Engelen, F J Gabreëls, O R Hommes, G F Borm, R A Wevers.   

Abstract

In this study levels of neuron-specific enolase (NSE), S-100 protein (S-100) and myelin basic protein (MBP) in cerebrospinal fluid (CSF) of children and adults with distinct neurological disorders were examined. A previous study from our department demonstrated age related reference values for these brain-specific proteins in CSF. The median concentration level of the 3 proteins in 17 different neurological disease groups versus the reference group was compared. Significantly higher MBP values were observed in patients with multiple sclerosis (MS), cerebrovascular accident (CVA), metabolic disorder and infection. Furthermore, significantly higher values were demonstrated for S-100 in CVA and for NSE in metabolic diseases. In CVA, the NSE and S-100 values were significantly related with MBP values, whereas in MS the NSE and S-100 were not related with MBP values.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7484080     DOI: 10.1111/j.1600-0404.1995.tb01696.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  17 in total

1.  Meningoencephalitis caused by Streptococcus pneumoniae: a diagnostic and therapeutic challenge. Diagnosis with diffusion-weighted MRI leading to treatment with corticosteroids.

Authors:  Philippe G Jorens; Paul M Parizel; Hendrik E Demey; Katrien Smets; Kris Jadoul; M M Verbeek; R A Wevers; Patrick Cras
Journal:  Neuroradiology       Date:  2005-09-07       Impact factor: 2.804

2.  Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.

Authors:  P J Jongen; K J Lamers; W H Doesburg; W A Lemmens; O R Hommes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

3.  Prediction of post-traumatic complaints after mild traumatic brain injury: early symptoms and biochemical markers.

Authors:  J R De Kruijk; P Leffers; P P C A Menheere; S Meerhoff; J Rutten; A Twijnstra
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

4.  High-resolution nuclear magnetic resonance spectroscopic study of metabolites in the cerebrospinal fluid of patients with cervical myelopathy and lumbar radiculopathy.

Authors:  Hideki Nagashima; Yasuo Morio; Shunsuke Meshitsuka; Koji Yamane; Yoshiro Nanjo; Ryota Teshima
Journal:  Eur Spine J       Date:  2010-05-20       Impact factor: 3.134

5.  Serum S100B levels in patients with lupus erythematosus: preliminary observation.

Authors:  Luis V C Portela; João C T Brenol; Roger Walz; Marino Bianchin; Adriano B L Tort; Ubirajara P Canabarro; Simone Beheregaray; João A Marasca; Ricardo M Xavier; Eurico C Neto; Carlos A Gonçalves; Diogo O Souza
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

6.  Intraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients.

Authors:  J de Vries; W A Thijssen; S E Snels; T Menovsky; N G Peer; K J Lamers
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

7.  In the rat brain acetyl-L-carnitine treatment modulates the expression of genes involved in neuronal ceroid lipofuscinosis.

Authors:  Giovanna Traina; Rodolfo Bernardi; Enrico Cataldo; Monica Macchi; Mauro Durante; Marcello Brunelli
Journal:  Mol Neurobiol       Date:  2008-08-23       Impact factor: 5.590

8.  Tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 in the cerebrospinal fluid of patients with cervical myelopathy and lumbar radiculopathy.

Authors:  Hideki Nagashima; Yasuo Morio; Koji Yamane; Yoshiro Nanjo; Ryota Teshima
Journal:  Eur Spine J       Date:  2009-06-19       Impact factor: 3.134

9.  Cerebrospinal fluid S-100 protein levels in neurological pathologies.

Authors:  J R Infante; A Martínez; J Ochoa; F Cañadillas; M Torres-Avisbal; J A Vallejo; F M González; C Pacheco; J M Latre
Journal:  J Physiol Biochem       Date:  2003-12       Impact factor: 4.158

10.  Molecular biomarkers in stroke diagnosis and prognosis.

Authors:  Matthew B Maas; Karen L Furie
Journal:  Biomark Med       Date:  2009-08-01       Impact factor: 2.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.